Immunology

Immunology includes companies working on autoimmune disease, inflammation, allergy, and immune-modulating therapies. This sector page brings together names focused on controlling overactive immune pathways or restoring immune balance across chronic inflammatory disorders.

Why watch Immunology

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Immunology news

The latest feed items from companies currently grouped under Immunology.

1. 01
   2026-10-08 05:00 EST

   ARGXargenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease

   Source: Argenx

2. 02
   2026-10-08 05:00 EST

   ARGXargenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease

   Source: Argenx

3. 03
   2026-10-07 20:05 EST

   ALECAlector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline

   Source: Alector

4. 04
   2026-10-07 12:00 EST

   KYTXKyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026

   Source: Kyverna Therapeutics

5. 05
   2026-10-07 05:00 EST

   NRIXNurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

   Source: Nurix Therapeutics

6. 06
   2026-10-06 20:05 EST

   EQEquillium Announces Poster Presentation at the 50th Anniversary La Jolla Immunology Conference

   Source: Equillium, Inc.

7. 07
   2026-10-06 13:00 EST

   INMBINmune Bio to Attend the 2026 Maxim Growth Summit

   Source: INmune Bio

8. 08
   2026-10-06 11:00 EST

   REGNRegeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026

   Source: Regeneron Pharmaceuticals

9. 09
   2026-10-06 00:13 EST

   SYRESpyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock

   Source: Spyre Therapeutics, Inc.

10. 10
    2026-10-05 20:05 EST

    ELDNEledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting

    Source: Eledon Pharmaceuticals, Inc.

11. 11
    2026-10-05 20:05 EST

    EQEquillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

    Source: Equillium, Inc.

12. 12
    2026-10-05 20:01 EST

    CABACabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Cabaletta Bio

13. 13
    2026-10-05 20:01 EST

    SYRESpyre Therapeutics Announces Proposed Public Offering of its Common Stock

    Source: Spyre Therapeutics, Inc.

14. 14
    2026-10-05 11:00 EST

    NRIXNurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences

    Source: Nurix Therapeutics

15. 15
    2026-10-05 11:00 EST

    ALECAlector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases

    Source: Alector

16. 16
    2026-10-02 20:05 EST

    VERAVera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Vera Therapeutics

17. 17
    2026-10-02 20:05 EST

    SYRESpyre Therapeutics Announces Grants of Inducement Awards

    Source: Spyre Therapeutics, Inc.

18. 18
    2026-10-02 13:24 EST

    VERAVera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026

    Source: Vera Therapeutics

19. 19
    2026-10-02 11:30 EST

    IFRXInflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026

    Source: Inflarx NV

20. 20
    2026-10-02 11:00 EST

    RNACCartesian Therapeutics Announces New Employment Inducement Grants

    Source: Cartesian Therapeutics

Companies in Immunology

89 companies tagged with Immunology.

Frequently Asked Questions